- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02808078
Gait Adaptation for Stroke Patients With Augmented Reality (GASPAR)
December 5, 2017 updated by: Philippe Terrier
Visually-guided Gait Training in Paretic Patients During First Rehabilitation: a Randomized Controlled Trial
The GASPAR trial is a pragmatic, parallel-arms, single-center, non-blinded, superiority randomized control trial in neurorehabilitation.
The main objective is to test whether a 4 weeks gait rehabilitation program that uses augmented reality is superior to a conventional treadmill training program of equivalent intensity.
Baseline assessments precede allocation, which consists in blocking randomization (2:1 ratio) with stratification according to the disease etiology.
Post-intervention assessments serve to compare the short-term efficacy of the intervention between the two groups.
Three months after discharge, follow-up assessments take place to detect potential long-term effects.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
After a lesion to the central nervous system, many patients suffer from a diminished walking capability.
During the first rehabilitation phase, specific cares help the recovery of motor function to offer the best chances of returning to normal walk.
For example, the repeated practice of walking exercises facilitates the gain of muscular strength and stimulates motor relearning.
However, in patients, who have finished the first rehabilitation phase, it is often observed strong limping, unsteady gait, and a bad management of obstacle clearance.
Thus, these individuals fall frequently, with risk of severe injury.
The aim of the study is to assess the efficacy of gait training on a treadmill equipped with an augmented reality system.
Shapes are displayed onto the treadmill belt with a projector (beamer): the patient adapts his/her gait to the drawing that unfolds in front of him/her.
It is possible to train gait symmetry for coordination enhancement or to exercise obstacle clearance and gait agility.
Another advantage of this type of treadmill is the capability to continuously analyze gait with integrated sensors and, hence, to give real-time feedback to the patient.
Whereas the method seems promising, thorough studies that would confirm its efficacy are lacking.
Therefore, the investigators seek to conduct a randomized controlled trial to compare visually-guided gait training with a more classical training method.
During four weeks, participants will train, according to their abilities, three to five times a week during 30 minutes on the augmented-reality treadmill.
A group of control patients will train at comparable intensity but without the visual guidance of gait.
Using the data collected during the training sessions, the investigators will study whether the evolution of locomotor function differs between both groups.
Furthermore, several questionnaires will be filled in by the participants to document the self-evaluation of their progress.
In the long term, the investigators expect to first improve the efficacy of gait rehabilitation and second to better understand the recovery process of locomotor function during the first months after a stroke.
Study Type
Interventional
Enrollment (Anticipated)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Philippe Terrier, PhD
- Phone Number: +41 27 603 2077
- Email: Philippe.Terrier@crr-suva.ch
Study Contact Backup
- Name: Cathia Rossano, MSc
- Phone Number: +41 27 603 2073
- Email: Cathia.Rossano@crr-suva.ch
Study Locations
-
-
Valais
-
Sion, Valais, Switzerland, 1951
- Recruiting
- Clinique romande de réadaptation
-
Contact:
- Philippe Terrier, PhD
- Email: Philippe.Terrier@crr-suva.ch
-
Contact:
- Rossano Cathia, MSc
- Email: Cathia.Rossano@crr-suva.ch
-
Principal Investigator:
- Philippe Terrier, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Participants fulfilling all of the following inclusion criteria are eligible for the study:
- Informed Consent as documented by signature
- Stroke patients, patients with traumatic brain injury, or patients with spinal cord injury in the acute to sub-acute phase (maximum 40 days after the incident)
- Need for gait rehabilitation in reason of at least one of the following conditions: Paresis of the lower extremities. Severe balance disorders. No walking at entry due to the neurological injury
- Ability to walk 2 minutes without or with minimal aid, namely: With the help of one person, or: With walking aid (cane, walker)
The presence of any one of the following exclusion criteria will lead to exclusion of the participant:
- Age < 18 years
- Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.) that may threaten the health in case of sustained exercise.
- Concomitant gait disorders induced by acute to sub-acute musculoskeletal injuries, e.g. fracture of the lower extremities.
- Severe pre-existent gait disorders that deeply affect walking abilities and gait pattern, either due to musculoskeletal (e.g. severe osteoarthritis) or neurological (e.g. Parkinson's disease) etiologies.
- Severe non-corrected visual impairment
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Augmented reality training
Gait training with augmented reality
|
20 sessions (30 min.
duration) over 4 weeks of gait training with augmented reality.
|
ACTIVE_COMPARATOR: Standard training
Gait training without augmented reality
|
20 sessions (30 min.
duration) over 4 weeks of gait training without augmented reality.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in walking speed
Time Frame: Pre-intervention (week 0), Post-intervention (week 5)
|
Walking speed, measured with the 2-minute walk test
|
Pre-intervention (week 0), Post-intervention (week 5)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in postural control
Time Frame: Pre-intervention (week 0), Post-intervention (week 5)
|
Capabilities to ensure an optimal postural control.
Measured with the Berg Balance test
|
Pre-intervention (week 0), Post-intervention (week 5)
|
Fear of falling during the hospitalization
Time Frame: week 5
|
Subjective assessment of the fear of falling.
Measured with the adapted Falls Efficacy Scale (FES)
|
week 5
|
Fear of falling at home
Time Frame: after discharge at 3-4 month
|
Subjective assessment of the fear of falling.
Measured with the adapted Falls Efficacy Scale (FES)
|
after discharge at 3-4 month
|
Quality of life at home
Time Frame: after discharge at 3-4 month
|
Short-Form 36 questionnaire (SF-36)
|
after discharge at 3-4 month
|
Perception of the intervention
Time Frame: During the intervention, week 2 and 4
|
purpose-designed questionnaire that will ask to the participant about their perception of the intervention.
The questionnaire will evaluate the satisfaction with intensity, duration and difficulty of the intervention.
Other questions will ask about the perceived training effects on walking speed and confidence.
|
During the intervention, week 2 and 4
|
Changes in stride and step lengths
Time Frame: In every gait training sessions, from week 1 to week 4
|
Measured with the embedded sensors of the treadmills
|
In every gait training sessions, from week 1 to week 4
|
Changes in stride and step durations
Time Frame: In every gait training sessions, from week 1 to week 4
|
Measured with the embedded sensors of the treadmills
|
In every gait training sessions, from week 1 to week 4
|
Change in step width
Time Frame: In every gait training sessions, from week 1 to week 4
|
Measured with the embedded sensors of the treadmills
|
In every gait training sessions, from week 1 to week 4
|
Change in left/right asymmetry of step lengths
Time Frame: In every gait training sessions, from week 1 to week 4
|
Measured with the embedded sensors of the treadmills
|
In every gait training sessions, from week 1 to week 4
|
Change in left/right asymmetry of step durations
Time Frame: In every gait training sessions, from week 1 to week 4
|
Measured with the embedded sensors of the treadmills
|
In every gait training sessions, from week 1 to week 4
|
Changes in stance and swing phases
Time Frame: In every gait training sessions, from week 1 to week 4
|
Measured with the embedded sensors of the treadmills
|
In every gait training sessions, from week 1 to week 4
|
Change in gait variability
Time Frame: In every gait training sessions, from week 1 to week 4
|
Stride-to-stride variability of gait parameters (outcomes 7-12)
|
In every gait training sessions, from week 1 to week 4
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Philippe Terrier, PhD, Institute for Research in Rehabilitation and Clinique romande de réadaptation
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2016
Primary Completion (ANTICIPATED)
July 1, 2018
Study Completion (ANTICIPATED)
December 1, 2018
Study Registration Dates
First Submitted
June 14, 2016
First Submitted That Met QC Criteria
June 16, 2016
First Posted (ESTIMATE)
June 21, 2016
Study Record Updates
Last Update Posted (ACTUAL)
December 6, 2017
Last Update Submitted That Met QC Criteria
December 5, 2017
Last Verified
December 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CliniqueRR-04
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
At the end of the study, final anonymized database will be made available through a specialized online repository
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on Gait training with augmented reality
-
Gazi UniversityCompletedParkinson DiseaseTurkey
-
Universitat de LleidaUniversity of Maryland, Baltimore; University of TurkuRecruiting
-
Hangang Sacred Heart HospitalNational Research Foundation of KoreaNot yet recruitingPain | Burns | Virtual Reality
-
IRCCS Eugenio MedeaUniversidad de Burgos; Asociatia Bucuresti Pentru Copii Dislexici; Augumented...Completed
-
VA Office of Research and DevelopmentCompletedTranstibial AmputationUnited States
-
University Hospital, Strasbourg, FranceRecruiting
-
Aristotle University Of ThessalonikiNot yet recruitingSpinal Cord InjuriesGreece
-
Aristotle University Of ThessalonikiNot yet recruiting
-
University Hospital, Clermont-FerrandActive, not recruitingMyoma;Uterus | Adenomyoma of UterusFrance
-
Tel-Aviv Sourasky Medical CenterUnknown